Curaleaf Holdings, Inc. (CURA.TO)
Toronto · CAD · Healthcare · Drug Manufacturers - Specialty & Generic
CA$11.87 (+5.69%) as of
Key statistics
- Market cap
- 3.14B
- Forward P/E
- -15.07
- EPS (TTM)
- -0.19
- Dividend yield
- 0.00%
- 52-week range
- 7.77 – 20.92
- Beta
- 1.60
- Revenue (TTM)
- 1.32B
- Profit margin
- -2.63%
- Analyst target
- CA$18.21
- Volume
- 81.44k
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Stamford, CT, United States
- Employees
- 5,554
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.